A Study for Absorption of Intranasal Epinephrine Compared to Conventional Intramuscular Epinephrine
- Registration Number
- NCT01432522
- Lead Sponsor
- Siriraj Hospital
- Brief Summary
This study is a preliminary report of pharmacokinetic data of epinephrine administered via intranasal route (IN) comparing with intramuscular (IM) route in healthy adult volunteers.
- Detailed Description
Patients are reluctant to use Epipen® on emergency basis, perhaps because of improperly training, hesitancy and fear of needle. Other route of administration of epinephrine (EPI) may be more benefit such as intranasal route.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 12
- Healthy subjects
- 18-30 years-old
- Pregnancy
- Subjected who use current medication that interfere with result of plasma epinephrine level such as pseudoephedrine
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description epinephrine IN, epinephrine IM, saline IN Epinephrine 1. Intranasal saline 2. Intramuscular epinephrine 3. Intranasal epinephrine
- Primary Outcome Measures
Name Time Method Composite of Pharmacokinetics of epinephrine predose, 5 , 10, 15, 20, 30, 45, 60, 90, 120, 180 minutes post-dose Cmax, Area Under Curve, Tmax of epinephrine compare between 0.3 mg intramuscular and 5 mg intranasal route
- Secondary Outcome Measures
Name Time Method Numbers of participants with adverse events as a measure of safety and tolerability 1 year Any side effects from such administration such as bad smelling, sorethroat.
Trial Locations
- Locations (1)
Facaulty of Medicine, Siriraj Hospital
🇹🇭Bangkok, Thailand